Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report

Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report

Published: May 2019
Publisher: MarketLine
Product ref: 310852
Pages: 36
Format: PDF
Delivery: By product vendor

Forward this to a colleague

Price: $175.00

Don't worry. No payment is taken yet


Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Key Highlights

Enzymotec Ltd (Enzymotec), a subsidiary of Frutarom Industries Ltd., produces, and markets of nutritional ingredients and medical foods for the entire human life-cycle such as from infancy to old age. The company develops clinically-validated products including bio-functional, lipid-based compounds compounds which meet a wide range of consumer demands on optimal development, supplementation for nutritional deficiencies and needs, and the management of medical disorders and diseases. Its major products include Infat, EnzyPS Solutions, Vayacog, Vayarin, Vayarol, NoctoPlex, LuciPlex, NoctoPlex for kids, and Addivance for kids. The company market products under Vayacog,INFAT,Vayarin, SHARP PS, SHARP PS GREEN,NOCTOPLEX, NOCTOPLEX for Kids, and LUCIPLEX brand names. The company has business presence in India, the US, China, and Sweden. Enzymotec is headquartered in Migdal HaEmek, Israel.


- Detailed information on Enzymotec Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Enzymotec Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Enzymotec Ltd including a breakdown and examination of key business segments
- Intelligence on Enzymotec Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Enzymotec Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Enzymotec Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Enzymotec Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Enzymotec Ltd's business structure, strategy and prospects.

Price: $175.00

Don't worry. No payment is taken yet

Need help before you order?

+44 (0)1527 573 736

9:00am - 5:30pm Mon - Fri

Related research categories

By company: SWOT analysis, Enzymotec

Not found what you were looking for?

Or contact our research team

We want to meet your research requirements. Let us know what you need, how to contact you and we will do the rest.

How do you want to be contacted?

Phone callback (one working day)

For enhanced security, please complete the following sum:

4 + 9 =

Forgot your password?